Wednesday, March 29, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Chemical Biological Applications and Risk Reduction Mission Support

by Global Biodefense Staff
November 9, 2015
CBARR Chemical Biological Applications Risk Reduction

The U.S. Army’s Chemical Biological Applications and Risk Reduction (CBARR) unit of Edgewood Chemical Biological Center (ECBC) has issued a draft mission support contract solicitation for operations, research and technology, and program and integration support.

The CBARR contract will be a single award indefinite delivery indefinite quantity (IDIQ) contract where task orders will be issued based on the unit’s needs. Specifically, CBARR efforts shall include:

  • Environmental sampling and analysis
  • Design and fabrication services
  • Chemical services support
  • Engineering control support
  • Data collection and analysis
  • Data and document management
  • Waste/materiel disposal and handling
  • Project management support

The CBARR effort will be solicited as a small business set-aside and will utilize a best value trade-off approach. The estimated contract period is 36 months.

A pre-proposal conference and tour of the relevant Aberdeen Proving Ground facilities is currently scheduled for Dec. 2, 2015. The purpose of the conference and the tour is to provide an overview of contract requirements and to allow Offerors an opportunity to view the Government equipment that may be utilized during contract performance. Further information regarding the conference and tour will be included in the forthcoming solicitation.

Further details are available via Solicitation Number: W911SR-15-R-CBAR.

Tags: Request for Proposals

Related Posts

Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC